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For all patients with ICH, surgical evacuation was associated with a higher
likelihood of survival without disability (odds ratio 2.1, 95% CI 0.95-4.7). The
prognosis for patients with both SOH and parenchymal hemorrhage was very
poor regardless of treatment strategy. Although the differences in outcome
may be due in part to selection of patients for operation with lower mortality
risk, physicians caring for patients with suspected intracranial hemorrhage
following thrombolytic therapy should consider early neurosurgical consul-
tation and intervention to potentially decrease patient disability and improve
survival.
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1756-1 I Non Surgical Septum Reduction: A New Treatment for
Hypertrophic Obstructive Cardiomyopathy (HOCM)
U. Sigwart, P. Buszman, C. Knight, R. Vecht, R. Sulton, D. Gibson. Royal Brompton
Hospital, London, UK.
In patients with HOCM and marked intraventricular gradients resistant to
conventional drug treatment with beta blockers and/or Verapamil surgical
resection of the muscular septal bulge has been advocated. We have inves-
tigated a new catheter treatment in 5 patients with HOCM and significant
LV ouflow tract gradients. All patients were in class 3 NYHA with angina and
shortness of breath. Intraventricular gradients were measured with transep-
tally introduced Brockenbrough catheters in the LV inflow tract and arterial
catheters in the aortic root. All patients were studied at rest, during the Val-
salva manoeuvre, after nitrates and after Isoproterenol infusion. The mea-
surements were repeated during balloon occlusion of the first major septal
branch of the left anterior descending coronary artery. - In all patients the
resting intraventricular gradient was reduced to less than 20 mm/Hg and
provocative testing (nitrates and post extrasystolic potentation) failed to cre-
ate typical increments. The longest inflation time was 30 minutes. Three pa-
tients had Verapamil 0.5 mg injected through the angioplasty balloon which
resulted in a longer lasting gradient/reduction after deflation of the balloon.
- After informed consent. 2 patient had 3-5 ml of desiccated alcohol infused
through the inflated balloon catheter in order to devitalise the offending my-
ocardium. This resulted in a CK elevation up to 2,500 units and permanent
abolition of the intraventricular gradient accompanied by marked clinical im-
provement.
From these preliminary observations we conclude that non surgical sep-
tum ablation maybe a promising new technique for the treatment of HOCM.
Further studies are warranted.
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Long Term Results of Dual Chamber (DOD) Pacing in
114 Adult Patients with Obstructive Hypertrophic
Cardiomyopathy and Severe Drug-Refractory
Symptoms
Dorothea McAreavey, Lameh Fananapazir. NIH, Bethesda, MD
Several studies indicate that short term, dual chamber (DOD) pacing relieves
symptoms and reduces LV outflow tract (LVOT) obstruction in hypertrophic
cardiomyopathy(HCM). We evaluated the long term outcome of DOD pacing
in 114 adult patients (age, 47 ± 15 yrs) with obstructive HCM and symptoms
refractory to {J-blocker and verapamil therapy. Three sudden deaths occurred
during a follow up period of 34 ± 10 months, maximum, 52 months (98%
3-year survival rate). At the last follow up evaluation, the NYHA functional
class improved significantly(3.1 ± 0.54 versus 1.7 ± 0.72, p < 0.0001). Thirty-
seven patients (32%) became asymptomatic. Symptoms were improved in
a further 62 patients (54%). However, 12 patients (10%) continued to have
disabling symptoms for various reasons: 8 had persistent LVOT obstruction
(in 3 patients an aberrant papillary muscle contributed to the LVOT obstruc-
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tion and in 3 patients, rapid AV node conduction prevented RV pacing). 3
patients had severe LV diastolic dysfunction, and 1 patient had mitral valve
prolapse and regurgitation. Seven of the 12 patients underwent corrective
cardiac surgery, and two patients are being considered for cardiac transplan-
tation. At a follow up cardiac catheterization after 14 ± 8 months of pacing,
there were significant reductions in LVOT gradient (79 ± 45 mmHg versus
26 ± 31 mmHg, p < 0.0001) and LV systolic pressure (188 ± 44 mmHg ver-
sus 147 ± 32 mmHg, p < 0.0001) comparing baseline and follow up mea-
surements. Aortic pulse pressure increased (45 ± 17 mmHg versus 52 ± 14
mmHg, p < 0.01).
These results suggest that long term, DOD pacing relieves symptoms and
LVOT obstruction in most HCM patients who would otherwise have been
candidates for cardiac surgery.
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1756-31 Management and Prognosis of Asymptomatic
Patients with Hypertrophic Cardiomyopathy
Paolo Spirito, Pietro Bellone, Paolo Bruzzi, Carlo Vecchio. Divisione di Cardiologia,
Ospedali Galliera, Genoa, Italy
The clinical course of hypertrophic cardiomyopathy (HCM) is extremely het-
erogeneous; some patients develop severe symptoms of heart failure, some
die suddenly, but many remain asymptomatic throughout life. The progno-
sis of patients who are asymptomatic at initial examination, however, has
never been investigated systematically in a large study population. We ex-
amined the clinical course of all the patients with HCM who were evaluated
in our department during 10 years and were asymptomatic or had only mild
symptoms at initial examination. A total of 89 patients were followed for a
mean of 4.9 yrs (0.3-10.8). Of these 89 patients, 50 (56%) were not treated
with cardioactive medications during follow up. Annual mortality was 0.4%
(95% confidence interval 0.1-1.4); only 2 patients died, both showing pro-
gressive deterioration before death. Seventy-nine patients (89%) remained
clinically stable during follow up, 3 developed severe symptoms (functional
class III). and 5 did not progress to class III but experienced sustained ven-
tricular tachycardia or syncope. Echocardiographic assessment of cardiac
morphology showed that the 2 patients who died were in the small group
of 8 patients with particularly marked hypertrophy (2:30 mm) at initial ex-
amination. In conclusion, our results show that cardiac mortality is low in
patients with HCM who are asymptomatic or have only mild symptoms, and
that clinical deterioration usually occurs gradually. In the absence of data
showing that therapy prevents cardiac death or delays disease progression
in HCM, our results suggest that treatment should be used only for allevia-
tion of symptoms.
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1756-41 Dual Chamber Pacing in Refractory Hypertrophic
Obstructive Cardiomyopathy: A Two-Center
European Experience in 34 Consecutive Patients
Nicolas Sadoul', Alistair K.B. Slade 2, Jean Philippe Simon 1, Richard
C. Saumarez 2, Bernard Dodinot 1, Etienne Allot 1, William J. McKenna 2.
1 Department of Cardiology, Nancy, France; 2 St. Georges Hospital Medical School,
London, UK
Dual chamber pacing with complete right ventricular capture has been re-
ported to improve symptoms in drug refractory hypertrophic obstructive car-
diomyopathy (HOCM). We report the joint experience of 34 consecutive im-
planted patients.
34 patients, (22 male, mean age 50 ± 18 yrs, range 16-79) with mean
symptom duration 7.5 yrs and refractory symptoms (angina: Class II n = 10,
III n = 12, dyspnoea: Class II n = 6, Class III n = 26, classe IV n = 1, syncope:
n = 13) were implanted after temporary dual chamber pacing had shown left
ventricular outflow tract gradient reduction of >30% as assessed by Doppler
Echocardiography.
After a mean follow-up of 10.2 ± 10.1 months (range 1-72). 33 patients
remained alive. Symptoms improved as follows. Syncope was eliminated
in all but 2 patients and 1 patient developed syncope after implant. Angina
improved in 14 but was unchanged in 4 patients and worsened in 4 and de-
veloped in 5. Dyspnoea was improved in 28/33 and unchanged in 5 patients.
Left ventricular outflow tract gradient decreased from 75 ± 29 (range = 36-
115) mmHg to 35 ± 27 (range 6-80) mmHg [p < 0.001 J. Patients who did not
improve were younger (mean age 36.6 yrs) and had a shorter follow-up.
Concfusion. Longer follow up after pacing for HCM sees re-emergence of
old and development of new symptoms in some patients despite continued
medical therapy.
